0.34% | % of shares held by all insiders |
107.35% | % of shares held by institutions |
107.72% | % of float held by institutions |
271 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
FMR, LLC | 9,726,041 | 30 Mar 2024 | 14.76% | 359,085,415 |
Wellington Management Group, LLP | 7,647,457 | 30 Mar 2024 | 11.60% | 282,344,098 |
Blackrock Inc. | 4,511,924 | 30 Mar 2024 | 6.85% | 166,580,225 |
Vanguard Group Inc | 3,650,582 | 30 Mar 2024 | 5.54% | 134,779,480 |
Eventide Asset Management LLC | 3,119,087 | 30 Mar 2024 | 4.73% | 115,156,686 |
Price (T.Rowe) Associates Inc | 3,087,208 | 30 Mar 2024 | 4.68% | 113,979,713 |
Polar Capital Holdings PLC | 3,059,492 | 30 Mar 2024 | 4.64% | 112,956,439 |
State Street Corporation | 2,979,751 | 30 Mar 2024 | 4.52% | 110,012,401 |
Kynam Capital Management, LP | 2,900,000 | 30 Mar 2024 | 4.40% | 107,067,994 |
Bellevue Group AG | 2,796,615 | 30 Mar 2024 | 4.24% | 103,251,020 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Specialized-Health Care Fund | 2,219,651 | 30 Jan 2024 | 3.37% | 81,949,510 |
Mutual Fund Ser Tr-Eventide Gilead Fund | 1,816,449 | 30 Dec 2023 | 2.76% | 67,063,293 |
Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 1,812,364 | 30 Dec 2023 | 2.75% | 66,912,475 |
Vanguard Total Stock Market Index Fund | 1,717,301 | 30 Dec 2023 | 2.61% | 63,402,749 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1,603,313 | 30 Mar 2024 | 2.43% | 59,194,313 |
iShares Russell 2000 ETF | 1,521,603 | 30 Mar 2024 | 2.31% | 56,177,579 |
Vanguard Explorer Fund, Inc. | 1,303,005 | 30 Jan 2024 | 1.98% | 48,106,942 |
Fidelity Select Portfolios - Biotechnology | 1,125,330 | 30 Mar 2024 | 1.71% | 41,547,181 |
Fidelity Advisor Growth Opportunities Fund | 936,700 | 30 Mar 2024 | 1.42% | 34,582,962 |
Vanguard Extended Market Index Fund | 805,231 | 30 Dec 2023 | 1.22% | 29,729,127 |